Entrada Therapeutics Reports Second Quarter 2025 Financial Results
Go back to Entrada Therapeutics Reports Second Quarter 2025 Financial Results| (NASDAQ: TRDA) | Delayed: 7.04 +0.09 (1.29%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.95 | 52 Week High | $ | |||
| Open | $7.00 | 52 Week Low | $ | |||
| Day High | $7.27 | P/E | N/A | |||
| Day Low | $6.93 | EPS | $ | |||
| Volume | 264,102 | |||||

